Individualization of Dosage Regimens in Obese Patients: Application to Acyclovir

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 9, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Obesity
Interventions
DRUG

Acyclovir

Subjects will receive a single dose of 5 mg/kg infused over 1 hour. Then, 13 blood samples after placement of a catheter, and 4 urine samples will be taken over the 12 hours following the start of administration

Trial Locations (1)

Unknown

RECRUITING

Toulouse Hospital, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER